Table 1 General data of patients in both groups before treatment(Mean ± SD).

From: Ultrasound guided transabdominal botulinum toxin injection for refractory overactive bladder treatment

 

Observation group (n = 32)

Control group(n = 32)

P value

Male/Female(n)

10/22

12/20

0.599

Age (year)

48.72 ± 6.24

45.91 ± 5.36

0.058

Complication (n,%)

Hypertension

13(40.63%)

17(53.13%)

0.317

Coronary disease

7(21.88%)

5(15.63%)

0.522

Diabetes

11(34.38%)

10(31.25%)

0.790

Hyperlipemia

19(29.38%)

22(68.75%)

0.435

Back to article page